MVP vs SPL

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

MVP

MEDICALDEV FPO [MVP]

57MEDIUM

SPL

STARPHARMA FPO [SPL]

58MEDIUM

Score Breakdown

MVP SPL
Technical
37
72
Catalyst
54
58
Sentiment
50
50
Fundamental
95
80
Momentum
49
80
Risk Gate
50
50

Key Metrics

MVP Metric SPL
$45.6MMarket Cap$315.7M
136KAvg Volume (20d)794K
N/AShort Interest+0.1%
$0.76552-Week High$0.790
$0.36552-Week Low$0.094
+0.0%Daily Change+5.1%
$0.405Reference Price$0.767
-0.8%ROE-14.5%
-1.1%Profit Margin-22.2%

Active Signals

MVP Signals

●MACD crossed bearish — momentum is fading
●Drifting lower — down 6.9% over the last 5 days
●Beating the Small Ords index — relative strength of 1.15, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●4C filed 2026-04-23
●Low P/S ratio (1.1x)
●Moderate revenue growth (+8%)

SPL Signals

●MACD momentum is picking up steam
●Pressing against the upper Bollinger Band — extended and may need to cool off
●Trading above both moving averages — the trend is your friend here
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Knocking on the door of resistance — if it punches through, things could get interesting
●Beating the Small Ords index — relative strength of 1.18, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (86 quarters)

Ask Scout AI to compare MVP and SPL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

MYX vs NSB →MYX vs NTI →MYX vs OCC →MYX vs PAR →MYX vs RCE →
MVP Full Analysis → SPL Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).